Eye News and Research

Latest Eye News and Research

Financial incentives from pharma companies can influence how vision care practitioners prescribe branded eyedrops

In a lookback study of prescribing patterns among thousands of American ophthalmologists and optometrists, Johns Hopkins Medicine researchers concluded that eye doctors who receive even small financial incentives from pharmaceutical companies, such as free food, sponsored travel to attend meetings or consulting fees, are up to twice as likely to prescribe the companies' brand name eyedrops for glaucoma instead of cheaper generic versions.

15 Aug 2022

‘Still a lot of pain’: Four years after mass shooting, Texas community grapples with fallout

In May 2018, after a high school shooting killed 10 people, the Santa Fe Resiliency Center opened in a church. Any resident could see a counselor, attend a support group, and take part in a healing mandala coloring class, music therapy, or a workshop on emotional first aid — all free of charge.

15 Aug 2022

Mount Sinai and Regeneron Genetics Center launch a new human genome sequencing research project

Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai have launched a new human genome sequencing research project called the Mount Sinai Million Health Discoveries Program with the Regeneron Genetics Center (RGC), part of the industry-leading, New York-based biotechnology company Regeneron.

12 Aug 2022

Vaccines and monoclonal antibodies being developed for respiratory syncytial virus

A new study reviews recent advancements made in the development of RSV immunoprophylactic measures.

11 Aug 2022

Crying out for new disease diagnoses

In this interview, we speak to Dr. Fei Liu and Dr. Luke P. Lee about their new iTears platform and how it could help to diagnose disease from tears.

11 Aug 2022

UIC focuses on developing an antiviral therapy for filoviruses

Researchers at the University of Illinois Chicago are working with the National Institutes of Health and researchers from across the country to establish a center for antiviral drug development for pandemic-level viruses, including Ebola and SARS-CoV-2, the virus that causes COVID-19.

11 Aug 2022

Study finds high level of resilience among children and adolescents living with glaucoma

Children and adolescents living with glaucoma develop a high level of emotional and social resilience to cope with this rare, chronic eye condition, a new Flinders University study reveals.

11 Aug 2022

Scientists discover new target for treatment of premature aging disorders

A stretch of DNA that hops around the human genome plays a role in premature aging disorders, scientists at the Salk Institute and King Abdullah University of Science and Technology in Saudi Arabia have discovered.

10 Aug 2022

Study uncovers new prognostic marker for multiple sclerosis severity

It is essential to assess the severity of multiple sclerosis (MS) in order to choose appropriate therapeutic measures, but this cannot be reliably done using existing methods.

10 Aug 2022

Study outlines strategies people with visual impairment use to navigate social challenges

A recent study highlights the range of uncomfortable situations people living with blindness or visual impairment encounter due to interpersonal communication challenges, and outlines strategies people with visual impairment use to navigate these situations.

9 Aug 2022

Mount Sinai receives $500,000 SU2C grant to identify therapeutic combinations for KRAS-mutant lung cancers

Mount Sinai is leading a team of lung cancer researchers that has been awarded a three-year, $500,000 grant from Stand Up To Cancer to explore therapeutic approaches to lung tumors with mutations in the KRAS gene, an undertaking that could have a significant impact for a large population of cancer patients who currently lack effective treatment options.

9 Aug 2022

WVU professor receives $1.6 million to expand research on brain circuits

A fruit fly walks on a rolling ball. As it meanders, Kevin Daly, biology professor at West Virginia University, looks deep into its brain through a specialized microscope.

9 Aug 2022

NIH researchers develop three-dimensional structure of twinkle protein

Researchers from the National Institutes of Health have developed a three-dimensional structure that allows them to see how and where disease mutations on the twinkle protein can lead to mitochondrial diseases.

5 Aug 2022

Vascular dysfunction may be the cause of metabolic changes that can lead to diabetes, study suggests

A major risk factor for diabetes, insulin resistance occurs when the cells of the body do not respond to insulin and cannot make use of the glucose (sugar) in the blood stream.

5 Aug 2022

KAIST researchers engineer a bacterial strain capable of producing lutein

A research group at KAIST has engineered a bacterial strain capable of producing lutein. The research team applied systems metabolic engineering strategies, including substrate channeling and electron channeling, to enhance the production of lutein in an engineered Escherichia coli strain.

4 Aug 2022

Discovery could prevent insulin resistance and have significant benefits for people with type 2 diabetes

In a potential game changer for patients with type 2 diabetes, a team of researchers at the Diabetes, Obesity, and Metabolism Institute (DOMI) at the Icahn School of Medicine at Mount Sinai has identified a therapeutic target for the preservation and regeneration of beta cells (β cells) - cells in the pancreas that produce and distribute insulin.

4 Aug 2022

New hydrogel treatment disrupts cavity-forming biofilms and whitens teeth

How effective is the recommendation of wearing glasses to protect against SARS-CoV-2 and other respiratory virus infection?

Researchers tested the effectiveness of wearing glasses in lowering the risk of contracting SARS-CoV-2 and other respiratory viral infections in community backdrop.

3 Aug 2022

Eye News and Research

Latest Eye News and Research

Financial incentives from pharma companies can influence how vision care practitioners prescribe branded eyedrops

‘Still a lot of pain’: Four years after mass shooting, Texas community grapples with fallout

Mount Sinai and Regeneron Genetics Center launch a new human genome sequencing research project

Vaccines and monoclonal antibodies being developed for respiratory syncytial virus

Crying out for new disease diagnoses

UIC focuses on developing an antiviral therapy for filoviruses

Study finds high level of resilience among children and adolescents living with glaucoma

Scientists discover new target for treatment of premature aging disorders

Study uncovers new prognostic marker for multiple sclerosis severity

Study outlines strategies people with visual impairment use to navigate social challenges

Mount Sinai receives $500,000 SU2C grant to identify therapeutic combinations for KRAS-mutant lung cancers

WVU professor receives $1.6 million to expand research on brain circuits

NIH researchers develop three-dimensional structure of twinkle protein

Vascular dysfunction may be the cause of metabolic changes that can lead to diabetes, study suggests

KAIST researchers engineer a bacterial strain capable of producing lutein

Discovery could prevent insulin resistance and have significant benefits for people with type 2 diabetes

New hydrogel treatment disrupts cavity-forming biofilms and whitens teeth

Inexpensive, self-driven microfluidic chip rapidly detects Hepatitis C virus in about 45 minutes

Case series of first 3 monkeypox patients in Massachusetts treated with tecoviromat

How effective is the recommendation of wearing glasses to protect against SARS-CoV-2 and other respiratory virus infection?

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Eye News and Research

Latest Eye News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in